Oral cavity cancer after sublingual buprenorphine use. Abruzzo AR, Harris MTH, Sroussi HY, Suzuki J, et al. Oral Oncol 2025;168:107573.

Read + Share

Amedeo Smart

Independent Medical Education

Abruzzo AR, Harris MTH, Sroussi HY, Suzuki J, et al. Oral cavity cancer after sublingual buprenorphine use. Oral Oncol 2025;168:107573.
PMID: 40769054